Literature DB >> 25093579

Immuno-miRs: critical regulators of T-cell development, function and ageing.

Bart-Jan Kroesen1, Nato Teteloshvili, Katarzyna Smigielska-Czepiel, Elisabeth Brouwer, Anne Mieke H Boots, Anke van den Berg, Joost Kluiver.   

Abstract

MicroRNAs (miRNAs) are instrumental to many aspects of immunity, including various levels of T-cell immunity. Over the last decade, crucial immune functions were shown to be regulated by specific miRNAs. These 'immuno-miRs' regulate generic cell biological processes in T cells, such as proliferation and apoptosis, as well as a number of T-cell-specific features that are fundamental to the development, differentiation and function of T cells. In this review, we give an overview of the current literature with respect to the role of miRNAs at various stages of T-cell development, maturation, differentiation, activation and ageing. Little is known about the involvement of miRNAs in thymic T-cell development, although miR-181a and miR-150 have been implicated herein. In contrast, several broadly expressed miRNAs including miR-21, miR-155 and miR-17~92, have now been shown to regulate T-cell activation. Other miRNAs, including miR-146a, show a more T-cell-subset-specific expression pattern and are involved in the regulation of processes unique to that specific T-cell subset. Importantly, differences in the miRNA target gene repertoires of different T-cell subsets allow similar miRNAs to control different T-cell-subset-specific functions. Interestingly, several of the here described immuno-miRs have also been implicated in T-cell ageing and there are clear indications for causal involvement of miRNAs in immunosenescence. It is concluded that immuno-miRs have a dynamic regulatory role in many aspects of T-cell differentiation, activation, function and ageing. An important notion when studying miRNAs in relation to T-cell biology is that specific immuno-miRs may have quite unrelated functions in closely related T-cell subsets.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  T cell; activation; ageing; differentiation; microRNA

Mesh:

Substances:

Year:  2015        PMID: 25093579      PMCID: PMC4264905          DOI: 10.1111/imm.12367

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  108 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  MicroRNAs, macrocontrol: regulation of miRNA processing.

Authors:  Izabella Slezak-Prochazka; Selvi Durmus; Bart-Jan Kroesen; Anke van den Berg
Journal:  RNA       Date:  2010-04-27       Impact factor: 4.942

3.  MicroRNA miR-125a controls hematopoietic stem cell number.

Authors:  Shangqin Guo; Jun Lu; Rita Schlanger; Hao Zhang; Judy Y Wang; Michelle C Fox; Louise E Purton; Heather H Fleming; Bradley Cobb; Matthias Merkenschlager; Todd R Golub; David T Scadden
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-08       Impact factor: 11.205

Review 4.  Plasticity of CD4+ T cell lineage differentiation.

Authors:  Liang Zhou; Mark M W Chong; Dan R Littman
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

5.  Macrophage development from HSCs requires PU.1-coordinated microRNA expression.

Authors:  Saeed Ghani; Pia Riemke; Jörg Schönheit; Dido Lenze; Jürgen Stumm; Maarten Hoogenkamp; Anne Lagendijk; Sven Heinz; Constanze Bonifer; Jeroen Bakkers; Salim Abdelilah-Seyfried; Michael Hummel; Frank Rosenbauer
Journal:  Blood       Date:  2011-07-05       Impact factor: 22.113

6.  Human activated CD4(+) T lymphocytes increase IL-2 expression by downregulating microRNA-181c.

Authors:  Qian Xue; Zhang-Yan Guo; Wei Li; Wei-Hong Wen; Yan-Ling Meng; Lin-Tao Jia; Jian Wang; Li-Bo Yao; Bo-Quan Jin; Tao Wang; An-Gang Yang
Journal:  Mol Immunol       Date:  2010-11-26       Impact factor: 4.407

7.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

8.  MiR-146a and NF-κB1 regulate mast cell survival and T lymphocyte differentiation.

Authors:  Nicole Rusca; Lorenzo Dehò; Sara Montagner; Christina E Zielinski; Antonio Sica; Federica Sallusto; Silvia Monticelli
Journal:  Mol Cell Biol       Date:  2012-08-27       Impact factor: 4.272

9.  B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element.

Authors:  Qinyan Yin; Xia Wang; Jane McBride; Claire Fewell; Erik Flemington
Journal:  J Biol Chem       Date:  2007-11-28       Impact factor: 5.157

10.  Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression.

Authors:  Florence Allantaz; Donavan T Cheng; Tobias Bergauer; Palanikumar Ravindran; Michel F Rossier; Martin Ebeling; Laura Badi; Bernhard Reis; Hans Bitter; Matilde D'Asaro; Alberto Chiappe; Sriram Sridhar; Gonzalo Duran Pacheco; Michael E Burczynski; Denis Hochstrasser; Jacky Vonderscher; Thomas Matthes
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

View more
  81 in total

Review 1.  Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis.

Authors:  Mingyi Wang; Soo Hyuk Kim; Robert E Monticone; Edward G Lakatta
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

Review 2.  Human T cell immunosenescence and inflammation in aging.

Authors:  Arsun Bektas; Shepherd H Schurman; Ranjan Sen; Luigi Ferrucci
Journal:  J Leukoc Biol       Date:  2017-07-21       Impact factor: 4.962

Review 3.  Epigenetic regulation of T helper cells and intestinal pathogenicity.

Authors:  Yuya Hagihara; Yusuke Yoshimatsu; Yohei Mikami; Yoshiaki Takada; Shinta Mizuno; Takanori Kanai
Journal:  Semin Immunopathol       Date:  2019-03-19       Impact factor: 9.623

4.  Circulating microRNAs: promising biomarkers in aplastic anemia.

Authors:  Jonathan B Bell; Sameem Abedin; Leonidas C Platanias
Journal:  Haematologica       Date:  2017-01       Impact factor: 9.941

5.  Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive Functions.

Authors:  Lucía Geis-Asteggiante; Ashton T Belew; Virginia K Clements; Nathan J Edwards; Suzanne Ostrand-Rosenberg; Najib M El-Sayed; Catherine Fenselau
Journal:  J Proteome Res       Date:  2017-11-27       Impact factor: 4.466

6.  Down-regulation of microRNA-451a facilitates the activation and proliferation of CD4+ T cells by targeting Myc in patients with dilated cardiomyopathy.

Authors:  Zhipeng Zeng; Ke Wang; Yuanyuan Li; Ni Xia; Shaofang Nie; Bingjie Lv; Min Zhang; Xin Tu; Qianqian Li; Tingting Tang; Xiang Cheng
Journal:  J Biol Chem       Date:  2016-12-14       Impact factor: 5.157

Review 7.  miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.

Authors:  Xiao-Min Xu; Hong-Jie Zhang
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

8.  MicroRNA 31 inhibits CD8+ T-cell function by increasing its sensitivity to type I interferon signaling in chronic viral infection.

Authors:  Mingming Jia; Yiming Shao; Kunxue Hong
Journal:  Cell Mol Immunol       Date:  2017-10-02       Impact factor: 11.530

9.  Expression profile of microRNAs following bone marrow-derived mesenchymal stem cell treatment in lipopolysaccharide-induced acute lung injury.

Authors:  Joonhong Park; Sikyoung Jeong; Kicheol Park; Keumjin Yang; Soyoung Shin
Journal:  Exp Ther Med       Date:  2018-05-02       Impact factor: 2.447

10.  A plasma microRNA signature as a biomarker for acquired aplastic anemia.

Authors:  Kohei Hosokawa; Sachiko Kajigaya; Xingmin Feng; Marie J Desierto; Maria Del Pilar Fernandez Ibanez; Olga Rios; Barbara Weinstein; Phillip Scheinberg; Danielle M Townsley; Neal S Young
Journal:  Haematologica       Date:  2016-09-22       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.